Maintenance Therapy for First-Line Metastatic Colorectal Cancer: Activity and Sustainability
Year: 2012
Type: article
Abstract: Results of a study, published in this issue of The Oncologist, comparing capecitabine and oxaliplatin plus bevacizumab with the same regimen for only six cycles followed by bevacizumab monotherapy in metastatic colorectal cancer patients are examined.
Source: The Oncologist
Authors: John H. Strickler, Herbert I. Hurwitz
Institution: Duke Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2145753255
